How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-40
SponsorGeorge Washington University

About this trial

This study aims to elucidate the differences in the gut microbiome functional activity and metabolome in adult premenopausal women with distinctive fitness levels and BMIs (with obesity, w/o obesity). The specific aims are as follows:

* Aim 1: To examine the effects of acute aerobic exercise at 60-70% heart rate reserve (HRRmax) for 30 minutes bout on changes in the abundance of SCFA-producing bacteria and their functional downstream metabolic activity. * Aim 2: To examine the effects of acute aerobic exercise at 60-70% HRRmax 30-minute bout on changes in GM-released SCFA concentrations in stool and plasmatic metabolome.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Biological sex: female

BMI 19 to 24.99 kg/m2 or BMI 30-40 kg/m2

Exercisers: Exercise at least 4 times per week for 60 minutes (a total of 240 minutes per week) on a programmed exercise training either on endurance sports (e.g., running, cycling, triathlon), strength (e.g., powerlifting), or team sports (e.g., rugby, football, soccer)

Non-Exercisers: Sedentary individuals who have not reached the PA guidelines (150 minutes of moderate-intensity physical activity a week, 75 minutes of vigorous-intensity physical activity, or an equivalent combination of moderate and vigorous-intensity physical activity).

Disqualifiers

Biological sex: male

BMI < 19 kg/m2 or > 40 kg/m2

Currently pregnant, < 2 years postpartum, lactating

Currently taking any herbal, fiber, or prebiotic supplement

Trial design

Design model

Single group

Treatments tested in this trial

  • Aerobic Exercise

    Behavioral

    30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Gut Microbiome Composition

Shotgun metagenomics will be used to examine the abundance of specific SCFA-producing bacteria in the stool (e.g., Ruminococcus)

Time frame
Before the exercise intervention and immediately after the intervention
2

Gut Microbiome Function

Shotgun metagenomics will be used to examine the BGCs (i.e., the genes within the microbial genome that dictate gut microbial functionality) to investigate functional downstream metabolic activity.

Time frame
Before the exercise intervention and immediately after the intervention
3

Plasma Metabolome

Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in plasma before and after the exercise intervention

Time frame
Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention
4

Stool Metabolome

Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in stool before and after the exercise intervention

Time frame
Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.